Related Experiment Video
Updated: Jul 12, 2025
10:09
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
8.3K
DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia
Huali Sun1, Yanling Ren2, Xinping Zhou2
1Department of Radiotherapy, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang, China.
Technology in Cancer Research & Treatment
|October 24, 2023
Summary
Dual specificity phosphatase 1 (DUSP1) is highly expressed in acute myeloid leukemia (AML) and linked to poor outcomes. Inhibiting DUSP1 may increase sensitivity to cytarabine (Ara-C) treatment in AML.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Dual specificity phosphatase 1 (DUSP1) is upregulated in various cancers.
- DUSP1 plays a key role in cellular responses to DNA-damaging agents.
- Understanding DUSP1's role in acute myeloid leukemia (AML) is crucial for treatment strategies.
Purpose of the Study:
- To investigate DUSP1 expression and its regulatory mechanisms in cytarabine (Ara-C) resistance in AML.
- To explore the correlation between DUSP1, the MAPK pathway, and immune microenvironment in AML.
Main Methods:
- Immunohistochemistry and Western blot for DUSP1 expression analysis.
- Quantitative PCR (Q-PCR) for mRNA levels.
- MTT assays and flow cytometry for cell proliferation and apoptosis.
- Protein-protein interaction (PPI) network analysis and immune infiltration analysis.
Main Results:
- DUSP1 expression is elevated in AML patients compared to controls.
- High DUSP1 levels correlate with poor clinical outcomes and are overexpressed in NRAS-mutated AML.
- DUSP1 knockdown sensitizes AML cells to Ara-C, increasing MAPK pathway phosphorylation.
- DUSP1 correlates with immune genes CREB1 and CXCL8, and tumor-infiltrating immune cells in RAS-mutated AML.
Conclusions:
- DUSP1 signaling pathways are implicated in regulating Ara-C sensitivity in AML.
- DUSP1 may serve as a potential therapeutic target for overcoming Ara-C resistance in AML.
Related Concept Videos
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:15Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K